Centrum Medyczne ENEL-MED S.A.

Centrum Medyczne ENEL-MED S.A.

GGPW:ENE
20.20
PLN
+0.20
(+1.00%)
0.26EPS
73.23P/E
540.15MMarket Cap
Dec 02Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.77
9.07
9.96
11.61
13.74
15.77
17.72
16.49
18.34
17.5
21.81
26.01
30.21
29.95
Basic EPS, GAAP
0.1
1.76
0.02
0.08
-0.14
-0.03
-0.1
-0.14
-0.06
-0.83
0.28
0.52
0.46
0.26
Free Cash Flow per Basic Share
0.63
0.16
-0.55
-0.37
-0.2
-0.21
1.93
2.62
1.19
-0.21
1.95
2.06
1.13
0.79
Dividend per Share
- -
- -
0.1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
2.88
4.64
4.56
4.62
4.5
4.44
4.34
4.2
6.21
5.38
5.59
6.11
6.57
6.6
Tangible Book Value per Share
2.74
4.51
4.39
4.42
4.26
4.14
4.01
3.86
5.68
4.66
4.84
5.36
5.84
5.84
Basic Weighted Avg Shares
24
24
24
24
24
24
24
24
24
28
28
28
28
30
Sales/Revenue/Turnover
207
214
235
274
324
372
418
400
441
495
617
736
854
885
Operating Margin (%)
3.71
2.59
0.98
1.67
-0.42
0.46
0.91
3.23
0.32
-4.1
0.47
3.11
2.52
2.64
Depreciation Expense
11
10
12
16
20
22
57
57
57
62
72
75
82
83
Net Income, GAAP
2
42
1
2
-3
-1
-2
-3
-1
-24
8
15
13
8
Effective Tax Rate (%)
24.12
0.2
57.42
45.72
- -
2,474.19
- -
- -
1,568.75
- -
10.86
23.69
20.95
21.39
Profit Margin (%)
1.18
19.44
0.24
0.67
-1.02
-0.2
-0.59
-0.85
-0.32
-4.76
1.29
1.99
1.51
0.87
Working Capital
-18
28
-3
-18
-20
-26
-54
-41
17
-45
-99
-45
-65
-65
LT Debt
26
13
21
22
30
29
205
199
160
169
181
229
285
292
Total Equity
68
110
107
109
106
105
102
99
176
152
158
173
186
187
Return on Invested Capital (%)
4.37
32.35
0.26
1.55
- -
-23.15
- -
- -
-19.03
- -
0.98
4.87
3.85
4.08
Return on Capital (%)
4.27
34.65
0.78
1.79
- -
-32.84
- -
- -
-22.17
- -
4.26
5.16
4.3
4.44
Return on Common Equity (%)
4.35
46.88
0.51
1.69
-3.08
-0.7
-2.38
-3.37
-1.03
-14.38
5.11
8.83
7.19
4.22

Capital Structure

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
57
57
59
LT Borrowings
11
17
23
LT Finance Leases
242
268
269
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
529
486
540

Working Capital

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
89
100
107
Cash, Cash Equivalents & STI
34
35
45
Accounts Receivable, Net
50
41
37
Inventories
4
4
4
Total Current Liabilities
151
165
172
Payables & Accruals
- -
- -
- -
ST Debt
57
57
59
Deferred Revenue
- -
- -
- -

Growth Rates

PLN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.69%
16.99%
7.58%
Free Cash Flow
-228.94%
-250.1%
-45.21%
Net Income, GAAP
159.55%
290.24%
-11.75%
Sales/Revenue/Turnover
14.04%
16.51%
16.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
177
182
184
192
736
2025
205
209
215
226
854
2026
236
- -
- -
- -
- -

Quarterly Earnings Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.04
0.45
-0.01
0.52
2025
0.22
-0.09
0.26
0.07
0.46
2026
0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jacek Jakub Rozwadowski
Full Time Employees
1,270
Sector
Finance
Industry
Life/Health insurance
Address
ul. Slominskiego 19 lok. 524 Warsaw Poland 00-195
IPO Date
Jun 14, 2011
Website
enel.pl
Business
Centrum Medyczne ENEL-MED S.A. operates as a leading private healthcare provider in Poland, delivering a comprehensive range of medical services including adult and pediatric specialist consultations, dentistry with implantology, prosthetics and orthodontics, orthopedic care, infertility treatment, rehabilitation, psychological support, imaging and laboratory diagnostics, emergency care, hospitalization with elective surgeries, aesthetic medicine, sports medicine under the enel-sport brand, and vaccination services for adults and children; it serves individual patients, families, corporate clients and those reimbursed by the National Health Fund through multi-profile clinics, hospitals, diagnostic centers and outpatient facilities. Founded in 1993 and headquartered in Warsaw at ul. Słomińskiego 19 lok. 524, the company manages the ENEL-MED Capital Group as parent entity with approximately 1,200 employees, primarily concentrating operations across major Polish cities such as Warsaw, Poznan, Lodz, Lublin and Mielec while maintaining a network of 42 departments, 35 multi-profile hospitals, 3 orthopedic clinics and 3 aesthetic medicine clinics. In recent developments, ENEL-MED triples its Warsaw footprint through a long-term 11-year lease expansion to 2,200 square meters at Signum Work Station in Mokotów secured in June 2025, enhancing diagnostic and therapeutic offerings as a flagship patient-focused facility following the property's acquisition by DRFG in December 2024; it registers statute changes in July 2025, signs investment credit agreements and related-party leases in June 2025 including with Mazowieckie Szpital Onkologiczny, and releases half-year 2025 financials in September alongside ongoing strategy for specialized centers in Warsaw.